Validation of FDG-PET segmentation tools for tumor delineation by correlation of CT- and PET volume measurements with histopathology of nodal metastases of head and neck carcinomas.

Validation of FDG-PET segmentation tools for tumor delineation by correlation of CT- and PET volume measurements with histopathology of nodal metastases of head and neck carcinomas. - Validation of FDG-PET segmentation tools.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32216

Enrollment

Registered

2008-05-26

Start date

2008-04-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plaveiselcelcarcinomen uitgaande van cavum oris, oropharynx, hypopharynx, larynx head and neck cancer squamous cell carcinoma of head and neck

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: •All patients with N+ squamous cell carcinoma of the head and neck, planned for neck dissection •Age >18 years

Exclusion criteria

Exclusion criteria: •Pregnancy •Women breast feeding

Design outcomes

Primary

Measure	Time frame
How accurate are the several FDG-PET segmentation tools in displaying the true tumor volume?	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results